FDA NDC Directory · JSON-LD · Markdown
NDC 16571-812 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Rising Pharma Holdings, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA212238 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | TRIENTINE HYDROCHLORIDE (500 mg/1) |
| Marketing started | 20230922 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).